Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11102-024-01473-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hypopituitarism and COVID-19, what else?
Pituitary
December 2024
Department of Internal Medicine, General Hospital 71, Mexican Social Security Institute, Veracruz, Mexico.
Hypopituitarism and COVID-19.
Pituitary
December 2024
Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Purpose: This review aims to collect and examine recent research findings regarding hypopituitarism and COVID-19, focusing on the virus's impact on the pituitary gland and the outcomes for infected patients with hormonal deficiencies.
Methods: Literature review using PubMed (pubmed.ncbi.
Painless thyroiditis associated with SARS-CoV-2 and influenza infections in a patient with central hypothyroidism after pituitary surgery.
Endocrinol Diabetes Metab Case Rep
October 2024
Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan.
Article Synopsis
COVID19 infection and vaccination and the risk of pituitary apoplexy: an entangled yarn.
Endocrine
October 2024
Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy.
Purpose: Pituitary apoplexy (PA) has been increasingly reported in association with both infection from and vaccination for COVID19. Our aim was to analyse the available published cases and compare the clinical characteristics in the two groups (infection vs vaccination).
Methods: We systematically reviewed the published literature for all cases of PA associated with COVID19 infection or vaccination.
Hypophysitis in COVID-19: a systematic review.
Pituitary
December 2024
Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Article Synopsis
- This systematic review investigates recent cases of hypophysitis—an inflammation of the pituitary gland—in patients who have recovered from COVID-19.
- Seven cases were studied, mainly involving young adults, with symptoms like headaches and increased thirst, emerging 2-3 weeks after COVID-19 symptoms.
- The findings showed various imaging results, with some patients receiving glucocorticoid treatment, but long-term follow-up data was limited, highlighting the rarity and unique presentation of COVID-related hypophysitis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!